Stay updated on STK-012 in Solid Tumors with Pembrolizumab Clinical Trial
Sign up to get notified when there's something new on the STK-012 in Solid Tumors with Pembrolizumab Clinical Trial page.

Latest updates to the STK-012 in Solid Tumors with Pembrolizumab Clinical Trial page
- Check5 days agoChange DetectedA service alert has been added regarding planned maintenance starting July 25th, during which most services will be unavailable for over 24 hours.SummaryDifference4%
- Check12 days agoChange DetectedThe web page has been updated to version 2.16.5, indicating a new release, while the previous version 2.16.4 has been removed. Additionally, information regarding the modernization of ClinicalTrials.gov data ingest scheduled for July 2025 has been deleted.SummaryDifference5%
- Check19 days agoNo Change Detected
- Check26 days agoChange DetectedThe expected modernization date for the ClinicalTrials.gov data ingest has been updated from June 2025 to July 2025.SummaryDifference4%
- Check33 days agoNo Change Detected
- Check40 days agoChange DetectedThe web page has been updated from version 2.16.1 to version 2.16.2.SummaryDifference0.3%
- Check48 days agoChange DetectedThe web page has been updated to indicate that the ClinicalTrials.gov data ingest will be modernized in June 2025, allowing API users to provide input before implementation. Additionally, the revision number has been updated from v2.15.2 to v2.16.1.SummaryDifference6%
- Check55 days agoChange DetectedThe content regarding 'STK-012 Monotherapy and in Combination Therapy in Patients With Solid Tumors' has been added to the page, indicating a potential update or introduction of new information related to this treatment.SummaryDifference0.3%
Stay in the know with updates to STK-012 in Solid Tumors with Pembrolizumab Clinical Trial
Enter your email address, and we'll notify you when there's something new on the STK-012 in Solid Tumors with Pembrolizumab Clinical Trial page.